A shelf registration statement relating to the shares of common stock offered in the public offering described above was filed with the
This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities being offered, nor shall there be any sale of the securities being offered in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
Any statements in this press release about future expectations, plans and prospects for
Senior Vice President
Corporate Strategy/Investor Relations
Vice President, Corporate Communications
Source: Aclaris Therapeutics, Inc.